No association of serotonin transporter polymorphism (5-HTTVNTR and 5-HTTLPR) with characteristics and treatment response to atypical antipsychotic agents in schizophrenic patients

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 33, Issue 2, 2009, Pages 276-280

  Lee, Hwa Young ^a   Kim, Dai Jin ^b   Lee, Heon Jeong ^a,c   Choi, Jung Eun ^c   Kim, Yong Ku ^a,c  

^a Korea University College of Medicine   (South Korea)

^b The Catholic University of Korea   (South Korea)

^c Korea University   (South Korea)

Author keywords

Polymorphism; Schizophrenia; Serotonin transporter; Therapeutic response

Indexed keywords

AMISULPRIDE; ARIPIPRAZOLE; OLANZAPINE; RISPERIDONE; SEROTONIN TRANSPORTER;

ADULT; ARTICLE; BARNES AKATHISIA RATING SCALE; BODY MASS; CALGARY DEPRESSION RATING SCALE FOR SCHIZOPHRENIA; CONTROLLED STUDY; DEPRESSION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE PREDISPOSITION; ETHNICITY; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; POSITIVE AND NEGATIVE SYNDROME SCALE; RATING SCALE; SCHIZOPHRENIA; SIMPSON ANGUS RATING SCALE; SYMPTOMATOLOGY; TANDEM REPEAT; TREATMENT RESPONSE;

ADULT; AGE OF ONSET; ANTIPSYCHOTIC AGENTS; BODY MASS INDEX; DNA; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; KOREA; MALE; POLYMORPHISM, GENETIC; PSYCHIATRIC STATUS RATING SCALES; PSYCHOMOTOR AGITATION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS;

EID: 60049083968     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2008.11.013     Document Type: Article

References (47)

1. Addington D., Addington J., and Schissel B. A depression rating scale for schizophrenics. Schizophr Res 3 (1990) 247-251
2. American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM-IV. 4th edition (1994), American Psychiatric Association, Washington DC
3. Baca-Garcia E., Vaquero-Lorenzo C., Diaz-Hernandez M., Rodriguez-Salgado B., Dolengevich-Segal H., Arrojo-Romero M., et al. Association between obsessive-compulsive disorder and a variable number of tandem repeats polymorphism in intron 2 of the serotonin transporter gene. Prog Neuropsychopharmacol Biol Psychiatry 31 (2007) 416-420
4. Barnes T.R. A rating scale for drug-induced akathisia. Br J Psychiatry 154 (1989) 672-676
5. Battersby S., Ogilvie A.D., Smith C.A., Blackwood D.H., Muir W.J., Quinn J.P., et al. Structure of a variable number tandem repeat of the serotonin transporter gene and association with affective disorder. Psychiatr Genet 6 (1996) 177-181
6. Bonnet-Brilhault F., Laurent C., Thibaut F., Campion D., Chavand O., Samolyk D., et al. Serotonin transporter gene polymorphism and schizophrenia: an association study. Biol Psychiatry 42 (1997) 634-636
7. Chong S.A., Lee W.L., Tan C.H., Tay A.H., Chan A.O., and Tan E.C. Attempted suicide and polymorphism of the serotonin transporter gene in Chinese patients with schizophrenia. Psychiatry Res 97 (2000) 101-106
8. Collier D.A., Arranz M.J., Sham P., Battersby S., Vallada H., Gill P., et al. The serotonin transporter is a potential susceptibility factor for bipolar affective disorder. Neuroreport 7 (1996) 1675-1679
9. Collier D.A., Stober G., Li T., Heils A., Catalano M., Di Bella D., et al. A novel functional polymorphism within the promoter of the serotonin transporter gene: possible role in susceptibility to affective disorders. Mol Psychiatry 1 (1996) 453-460
10. Emsley R., Rabinowitz J., and Medori R. Time course for antipsychotic treatment response in first-episode schizophrenia. Am J Psychiatr 163 (2006) 743-745
11. Fan J.B., and Sklar P. Meta-analysis reveals association between serotonin transporter gene STin2 VNTR polymorphism and schizophrenia. Mol Psychiatry 10 (2005) 928-938 [891]
12. Fiskerstrand C.E., Lovejoy E.A., and Quinn J.P. An intronic polymorphic domain often associated with susceptibility to affective disorders has allele dependent differential enhancer activity in embryonic stem cells. FEBS Lett 458 (1999) 171-174
13. Golimbet V.E., Shcherbatykh T.V., Abramova L.I., Kaleda V.G., Oleichik I.V., Orlova V.A., et al. Serotonin transporter gene polymorphism in families with schizophrenia. Zh Nevrol Psikhiatr Im S S Korsakova vol. 101 (2001) 40-41
14. Gordon D., Finch S.J., Nothnagel M., and Ott J. Power and sample size calculations for case-control genetic association tests when errors are present: application to single nucleotide polymorphisms. Hum Hered 54 (2002) 22-33
15. Gordon D., Levenstien M.A., Finch S.J., and Ott J. Errors and linkage disequilibrium interact multiplicatively when computing sample sizes for genetic case-control association studies. Pac Symp Biocomput (2003) 490-501
16. Gottesman I. Schizophrenia genesis: the origins of madness (1999), WH Freeman & Co., New York
17. Greenberg B.D., Tolliver T.J., Huang S.J., Li Q., Bengel D., and Murphy D.L. Genetic variation in the serotonin transporter promoter region affects serotonin uptake in human blood platelets. Am J Med Genet 88 (1999) 83-87
18. Han O., and Hong J. Structured clinical interview for DSM-IV Axis I disorders-Korean version (2000), Hana Medical Publishing, Seoul
19. Heils A., Teufel A., Petri S., Stober G., Riederer P., Bengel D., et al. Allelic variation of human serotonin transporter gene expression. J Neurochem 66 (1996) 2621-2624
20. Herken H., Erdal M.E., Aynacioglu A.S., Barlas O., Cataloluk O., Esgi K., et al. Frequency of the 17-bp variable number of tandem repeat polymorphism in Turkish schizophrenic patients. Schizophr Res 58 (2002) 99-100
21. Hranilovic D., Stefulj J., Schwab S., Borrmann-Hassenbach M., Albus M., Jernej B., et al. Serotonin transporter promoter and intron 2 polymorphisms: relationship between allelic variants and gene expression. Biol Psychiatry 55 (2004) 1090-1094
22. Hranilovic D., Stefulj J., Schwab S., Borrmann-Hassenbach M., Albus M., Jernej B., et al. Serotonin transporter promoter and intron 2 polymorphisms: relationship between allelic variants and gene expression. Biol Psychiatry 55 (2004) 1090-1094
23. Kaiser R., Tremblay P.B., Schmider J., Henneken M., Dettling M., Muller-Oerlinghausen B., et al. Serotonin transporter polymorphisms: no association with response to antipsychotic treatment, but associations with the schizoparanoid and residual subtypes of schizophrenia. Mol Psychiatry 6 (2001) 179-185
24. Kane J.M. Extrapyramidal side effects are unacceptable. Eur Neuropsychopharmacol 11 Suppl 4 (2001) S397-S403
25. Kay S.R., Fiszbein A., and Opler L.A. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 13 (1987) 261-276
26. Kim Y.K., Won S.D., Lee K.M., Choi H.S., Jang H.S., Lee B.H., et al. A study on the reliability and validity of the Korean version of the Calgary depression for schizophrenia(K-CDSS). J Korean Neuropsychiatr Assoc 44 (2005) 446-455
27. Lesch K.P., and Mossner R. Genetically driven variation in serotonin uptake: is there a link to affective spectrum, neurodevelopmental, and neurodegenerative disorders?. Biol Psychiatry 44 (1998) 179-192
28. Lesch K.P., Balling U., Gross J., Strauss K., Wolozin B.L., Murphy D.L., et al. Organization of the human serotonin transporter gene. J Neural Transm Gen Sect 95 (1994) 157-162
29. Lesch K.P., Bengel D., Heils A., Sabol S.Z., Greenberg B.D., Petri S., et al. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 274 (1996) 1527-1531
30. Liu W., Gu N., Feng G., Li S., Bai S., Zhang J., et al. Tentative association of the serotonin transporter with schizophrenia and unipolar depression but not with bipolar disorder in Han Chinese. Pharmacogenetics 9 (1999) 491-495
31. MacKenzie A., and Quinn J. A serotonin transporter gene intron 2 polymorphic region, correlated with affective disorders, has allele-dependent differential enhancer-like properties in the mouse embryo. Proc Natl Acad Sci U S A 96 (1999) 15251-15255
32. Malhotra A.K., Goldman D., Mazzanti C., Clifton A., Breier A., and Pickar D. A functional serotonin transporter (5-HTT) polymorphism is associated with psychosis in neuroleptic-free schizophrenics. Mol Psychiatry 3 (1998) 328-332
33. Mata-Pastor I., Arranz-Calderon M.J., Beperet-Urmeneta M., Perez-Nievas F., Sham P., and Kerwin R. Influence of serotonergic transmission on response to olanzapine. Actas Esp Psiquiatr 30 (2002) 265-271
34. Ogilvie A.D., Battersby S., Bubb V.J., Fink G., Harmar A.J., Goodwim G.M., et al. Polymorphism in serotonin transporter gene associated with susceptibility to major depression. Lancet 347 (1996) 731-733
35. Pae C., Kim T., Kim J., Lee C., Lee S., Lee C., et al. The serotonin transporter gene polymorphism may not be associated with antipsychotic treatment response in patients with schizophrenia. Psychiatr Invest 2 (2005) 98-103
36. Rees M., Norton N., Jones I., McCandless F., Scourfield J., Holmans P., et al. Association studies of bipolar disorder at the human serotonin transporter gene (hSERT; 5HTT). Mol Psychiatry 2 (1997) 398-402
37. Serretti A., Catalano M., and Smeraldi E. Serotonin transporter gene is not associated with symptomatology of schizophrenia. Schizophr Res 35 (1999) 33-39
38. Serretti A., Lilli R., Lorenzi C., Lattuada E., Cusin C., and Smeraldi E. Serotonin transporter gene (5-HTTLPR) and major psychoses. Mol Psychiatry 7 (2002) 95-99
39. Shcherbatykh T.V., Golimbet V.E., Orlova V.A., and Kaleda V.G. Polymorphism in the human serotonin transporter gene in endogenous psychoses. Genetika 36 (2000) 1712-1715
40. Shcherbatykh T.V., Golimbet V.E., Orlova V.A., and Kaleda V.G. [Polymorphism in the human serotonin transporter gene in endogenous psychoses]. Genetika 36 (2000) 1712-1715
41. Simpson G.M., and Angus J.W. A rating scale for extrapyramidal side effects. Acta Psychiatr Scand Suppl 212 (1970) 11-19
42. Stober G., Heils A., and Lesch K.P. Serotonin transporter gene polymorphism and affective disorder. Lancet 347 (1996) 1340-1341
43. Stober G., Jatzke S., Heils A., Jungkunz G., Fuchs E., Knapp M., et al. Susceptibility for schizophrenia is not influenced by a functional insertion/deletion variant in the promoter of the serotonin transporter gene. Eur Arch Psychiatry Clin Neurosci 248 (1998) 82-86
44. Tandon R. Safety and tolerability: how do newer generation "atypical" antipsychotics compare?. Psychiatr Q 73 (2002) 297-311
45. Tsai S.J., Hong C.J., Yu Y.W., Lin C.H., Song H.L., Lai H.C., et al. Association study of a functional serotonin transporter gene polymorphism with schizophrenia, psychopathology and clozapine response. Schizophr Res 44 (2000) 177-181
46. Tsai S.J., Ouyang W.C., and Hong C.J. Association for serotonin transporter gene variable number tandem repeat polymorphism and schizophrenic disorders. Neuropsychobiology 45 (2002) 131-133
47. Zainullina A.G., Iur'ev E.B., Bikbulatova S.R., and Khusnutdinova E.K. Association of the hSERT and SLC6A4 polymorphic markers of the serotonin transporter gene with schizophrenia in different ethnic groups. Mol Biol (Mosk) 37 (2003) 601-606